Priyanka Choudhary
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Priyanka Choudhary has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Alok Singh
Department of Veterinary Medicine, College of Veterinary and Animal Sciences, GBPUA&T, Pantnagar, Uttarakhand, India
2 shared publications - Gollahalli Eregowda Chethan
Department of Veterinary Medicine, College of Veterinary Sciences and Animal Husbandry, Aizawl, Mizoram, Central Agricultural University, Imphal, India
2 shared publications - Mahesh Kumar
Department of Veterinary Medicine, College of Veterinary and Animal Sciences, GBPUA&T, Pantnagar, Uttarakhand, India
2 shared publications - Neeraj Thakur
Department of Veterinary Medicine, College of Veterinary Sciences and Animal Husbandry, Aizawl, Mizoram, Central Agricultural University, Imphal, India
2 shared publications - S. K. Shukla
Department of Veterinary Medicine, College of Veterinary and Animal Sciences, GBPUA&T, Pantnagar, Uttarakhand, India
2 shared publications - Abhay Motiramji Gaidhane
Dept of Community Medicine, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research Deemed to be University, Wardha, Maharshtra, India
1 shared publication
Latest Publications
- Open Access
- 20 August 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (10) , 6409-6424
Nephroprotective effects of Zanthoxylum armatum DC. extract via modulation of oxidative and nitrosative stress in acute kidney injury in rats
Background: Zanthoxylum armatum DC. has anti-inflammatory, antibacterial, antioxidant, and antipyretic properties, which are widely recognized. In this study, phytochemical components, antioxidant efficacy, in vivo nephroprotective activity, and immunomodulatory potential of Z. armatum DC. hydroethanolic extract have been investigated in a gentamicin-induced acute kidney injury (AKI) rat model. Methods: Rats treated with gentamicin (100 mg/kg) for 8 days were administered Zanthoxylum armatum DC. extract. Based on biochemistry, oxidative stress indices, cytokine levels, kidney injury biomarkers, and histopathology, the nephroprotective and immunomodulatory efficacy of Z. armatum DC. extract was evaluated. Results: Catalase, glutathione reductase, superoxide dismutase, and interleukin-10 levels in blood and tissue homogenates decreased due to gentamicin toxicity, whereas serum creatinine, blood urea nitrogen, lipid peroxide, tumor necrosis factor-alpha, cystatin C, kidney injury molecule-1, and gamma-glutamyl transpeptidase levels elevated. Zanthoxylum armatum DC. treatment reduced kidney damage, cytokine imbalance, and oxidative stress; however, results were nearly similar to standard drug. The organoprotective efficacy of Z. armatum DC. was further validated by histopathology of kidney, liver, and heart tissues. Conclusion: The present research shows that Z. armatum DC. can ameliorate gentamicin-induced AKI, which may be attributed to its antioxidant properties, phenolic and flavonoid phytoconstituents, and ability to suppress inflammatory cytokines. Further studies may therefore be developed to assess its safety and efficacy for clinical trials. Statement of Novelty: Z. armatum DC. hydroethanolic extract has various properties like antioxidant, organoprotective, anti-inflammatory, and potential to inhibit biochemical parameters involved in renal impairment via blocking p38 mitogen-activated protein kinase/nuclear factor kappa B p65 signaling pathway.
- 20 August 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (10) , 6409-6424
Open AccessNephroprotective effects of Zanthoxylum armatum DC. extract via modulation of oxidative and nitrosative stress in acute kidney injury in rats
Background: Zanthoxylum armatum DC. has anti-inflammatory, antibacterial, antioxidant, and antipyretic properties, which are widely recognized. In this study, phytochemical components, antioxidant efficacy, in vivo nephroprotective activity, and immunomodulatory potential of Z. armatum DC. hydroethanolic extract have been investigated in a gentamicin-induced acute kidney injury (AKI) rat model. Methods: Rats treated with gentamicin (100 mg/kg) for 8 days were administered Zanthoxylum armatum DC. extract. Based on biochemistry, oxidative stress indices, cytokine levels, kidney injury biomarkers, and histopathology, the nephroprotective and immunomodulatory efficacy of Z. armatum DC. extract was evaluated. Results: Catalase, glutathione reductase, superoxide dismutase, and interleukin-10 levels in blood and tissue homogenates decreased due to gentamicin toxicity, whereas serum creatinine, blood urea nitrogen, lipid peroxide, tumor necrosis factor-alpha, cystatin C, kidney injury molecule-1, and gamma-glutamyl transpeptidase levels elevated. Zanthoxylum armatum DC. treatment reduced kidney damage, cytokine imbalance, and oxidative stress; however, results were nearly similar to standard drug. The organoprotective efficacy of Z. armatum DC. was further validated by histopathology of kidney, liver, and heart tissues. Conclusion: The present research shows that Z. armatum DC. can ameliorate gentamicin-induced AKI, which may be attributed to its antioxidant properties, phenolic and flavonoid phytoconstituents, and ability to suppress inflammatory cytokines. Further studies may therefore be developed to assess its safety and efficacy for clinical trials. Statement of Novelty: Z. armatum DC. hydroethanolic extract has various properties like antioxidant, organoprotective, anti-inflammatory, and potential to inhibit biochemical parameters involved in renal impairment via blocking p38 mitogen-activated protein kinase/nuclear factor kappa B p65 signaling pathway.
- 10 April 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (10) , 3117-3129
Prevalence of BK virus and BK virus-associated hemorrhagic cystitis in stem cell transplant recipients: a systematic review and meta-analysis
Background The BK virus (BKV) commonly affects stem cell transplant (SCT) patients and can lead to hemorrhagic cystitis (HC), a serious condition that negatively impacts patient health. This study reviews the frequency of BKV infections in SCT patients, particularly those who develop HC. Methods We searched Web of Science, PubMed, and Embase up to August 10, 2024, to identify relevant articles focusing on the prevalence of BKV-related hemorrhagic cystitis (HC) in stem cell transplant (SCT) patients. Two reviewers independently screened and extracted data using Nested Knowledge software. A meta-analysis of pooled prevalence rates was conducted using random-effects models in R software, version 4.4. Study heterogeneity was assessed with the I2 statistic, and study quality was evaluated using a modified Newcastle–Ottawa Scale (NOS). Trim-and-fill funnel plot and Eggers test were used to assess publication bias. Results Of the 2700 articles identified, 15 met our inclusion criteria, encompassing 7856 participants. The overall pooled prevalence of BKV-related hemorrhagic cystitis (HC) was 12.8% (95% CI 8.7–18.5%), with rates varying significantly from 5.0 to 45.9%. This variation reflects differences in patient backgrounds, transplant methods, and diagnostic approaches (I2 = 97%). The prevalence of BKV infections without HC was 45.8% (95% CI 14.0–81.4%), also showing wide variation from 0.8 to 94.7% and high heterogeneity (I2 = 99%). Conclusions Our study identified a substantial prevalence of BKV-associated hemorrhagic cystitis in stem cell transplant patients, highlighting the importance of vigilant monitoring and effective treatment strategies to manage this risk. Enhancing both diagnostic techniques and treatment approaches is crucial for improving patient outcomes.
- 10 April 2025
- Published by Springer Nature in International Urology and Nephrology
- Vol. 57 (10) , 3117-3129
Prevalence of BK virus and BK virus-associated hemorrhagic cystitis in stem cell transplant recipients: a systematic review and meta-analysis
Background The BK virus (BKV) commonly affects stem cell transplant (SCT) patients and can lead to hemorrhagic cystitis (HC), a serious condition that negatively impacts patient health. This study reviews the frequency of BKV infections in SCT patients, particularly those who develop HC. Methods We searched Web of Science, PubMed, and Embase up to August 10, 2024, to identify relevant articles focusing on the prevalence of BKV-related hemorrhagic cystitis (HC) in stem cell transplant (SCT) patients. Two reviewers independently screened and extracted data using Nested Knowledge software. A meta-analysis of pooled prevalence rates was conducted using random-effects models in R software, version 4.4. Study heterogeneity was assessed with the I2 statistic, and study quality was evaluated using a modified Newcastle–Ottawa Scale (NOS). Trim-and-fill funnel plot and Eggers test were used to assess publication bias. Results Of the 2700 articles identified, 15 met our inclusion criteria, encompassing 7856 participants. The overall pooled prevalence of BKV-related hemorrhagic cystitis (HC) was 12.8% (95% CI 8.7–18.5%), with rates varying significantly from 5.0 to 45.9%. This variation reflects differences in patient backgrounds, transplant methods, and diagnostic approaches (I2 = 97%). The prevalence of BKV infections without HC was 45.8% (95% CI 14.0–81.4%), also showing wide variation from 0.8 to 94.7% and high heterogeneity (I2 = 99%). Conclusions Our study identified a substantial prevalence of BKV-associated hemorrhagic cystitis in stem cell transplant patients, highlighting the importance of vigilant monitoring and effective treatment strategies to manage this risk. Enhancing both diagnostic techniques and treatment approaches is crucial for improving patient outcomes.
- Open Access
- 2 April 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (5) , 2674-2688
Alteration in oxidative/nitrosative disparity and nephroprotective effect of hydroethanolic extract of Ocimum tenuiflorum L. in gentamicin-induced acute kidney injury
Background: Antibacterial, antioxidant, and antilipidemic properties of Ocimum tenuiflorum are well known from previous studies. This study was designed to study the phytochemical constituents, antioxidant efficacy, in vivo nephroprotective activity, and immunomodulatory potential of Ocimum tenuiflorum hydroethanolic extract in gentamicin-induced acute kidney injury (AKI) rat model. Methods: Ocimum tenuiflorum extract was given for 8 days to gentamicin-induced toxicity (100 mg/kg) in rats. Nephroprotective and immunomodulatory efficacy of O. tenuiflorum extract was evaluated based on urine and serum biochemistry, blood and tissue oxidative stress indices, cytokine levels, kidney injury biomarkers, and histopathology. Results: Gentamicin toxicity resulted in a reduction in catalase, glutathione reductase, superoxide dismutase, and interleukin-10 levels in blood and tissue homogenates, while an increase in serum creatinine, blood urea nitrogen, lipid peroxide, tumor necrosis factor-alpha, cystatin C, kidney injury molecule-1, and gamma-glutamyl transpeptidase levels. Treatment with O. tenuiflorum ameliorated oxidative stress, cytokine imbalance, and kidney injury; however, the results were almost similar to standard drug. Furthermore, histopathological analysis of kidney, liver, and heart tissues confirmed the organoprotective efficacy of O. tenuiflorum extract. Conclusion: The present findings demonstrate the curative efficacy of O. tenuiflorum in gentamicin-induced AKI, probably mediated through phenolic and flavonoid phytoconstituents, antioxidant properties, and down-regulation of inflammatory cytokines. Therefore, future studies may be established to evaluate its efficacy and safety for clinical trials.
- 2 April 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (5) , 2674-2688
Open AccessAlteration in oxidative/nitrosative disparity and nephroprotective effect of hydroethanolic extract of Ocimum tenuiflorum L. in gentamicin-induced acute kidney injury
Background: Antibacterial, antioxidant, and antilipidemic properties of Ocimum tenuiflorum are well known from previous studies. This study was designed to study the phytochemical constituents, antioxidant efficacy, in vivo nephroprotective activity, and immunomodulatory potential of Ocimum tenuiflorum hydroethanolic extract in gentamicin-induced acute kidney injury (AKI) rat model. Methods: Ocimum tenuiflorum extract was given for 8 days to gentamicin-induced toxicity (100 mg/kg) in rats. Nephroprotective and immunomodulatory efficacy of O. tenuiflorum extract was evaluated based on urine and serum biochemistry, blood and tissue oxidative stress indices, cytokine levels, kidney injury biomarkers, and histopathology. Results: Gentamicin toxicity resulted in a reduction in catalase, glutathione reductase, superoxide dismutase, and interleukin-10 levels in blood and tissue homogenates, while an increase in serum creatinine, blood urea nitrogen, lipid peroxide, tumor necrosis factor-alpha, cystatin C, kidney injury molecule-1, and gamma-glutamyl transpeptidase levels. Treatment with O. tenuiflorum ameliorated oxidative stress, cytokine imbalance, and kidney injury; however, the results were almost similar to standard drug. Furthermore, histopathological analysis of kidney, liver, and heart tissues confirmed the organoprotective efficacy of O. tenuiflorum extract. Conclusion: The present findings demonstrate the curative efficacy of O. tenuiflorum in gentamicin-induced AKI, probably mediated through phenolic and flavonoid phytoconstituents, antioxidant properties, and down-regulation of inflammatory cytokines. Therefore, future studies may be established to evaluate its efficacy and safety for clinical trials.
- Open Access
- 17 September 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (12) , 7434-7446
Quantitative tissue analysis reveals AK2, COL1A1, and PLG protein signatures: targeted therapeutics for meningioma
Background: Meningioma is the most prevalent primary intracranial brain tumor and accounts for one-third of all CNS tumors. Meningioma is known to be the most common yet life-threatening brain tumor with a higher recurrence rate. Globally, there is an increase in the healthcare burden due to meningioma and hence in its research. The present clinical approach includes surgical resection, chemotherapy, and radiation therapies to which the malignancy does not seem to respond efficiently. Targeted therapies and molecular markers provide elite patient treatment and care for individuals suffering from meningiomas as compared to conventional measures. Although there is proteomic data on meningioma the knowledge of potential biomarkers differentiating the grades is scarce. To identify the best set of biomarkers, validation of reported markers in large and independent sample cohorts in the future is necessary. Methods: A total of 12 samples, 3 each of control (which made pool 1) meningioma grade I (which made 2 sets: pool 2 and pool 3), and meningioma grade II (which made pool 4) were taken for LC-MS/MS. After this, the expression of three proteins was checked by immunocytochemistry, flow cytometry, and western blotting. Results: Protein expression was analyzed using various techniques like mass spectrometry, immunocytochemistry, flow cytometry, and western blotting. Mass spectrometry is the most commonly used standard and reliable technique for identifying and quantifying protein expression. We got three highly upregulated proteins namely AK2, COL1A1, and PLG using this technique. The biomarker potential of these proteins was further checked by ICC, western blotting, and flow cytometry. Three important proteins were found to be upregulated namely, AK2 (Adenylate kinase 2), COL1A1 (collagen 1A1), and PLG (plasminogen). The order of increased protein expression was control < MG grade I < MG grade II according to mass spectrometry and western blotting. In immunocytochemistry, we found that COL1A1 expression increases significantly with grades in comparison to control. Similarly, AK2 and PLG also showed little increase but not as much as COL1A1. In flow cytometry, PLG showed higher upregulation in grades than control. While AK2 and COL1A1 showed little increase in expression in grades than control. All techniques, especially mass spectrometry and western blotting, presented higher expression of these proteins in grades as compared to control. Conclusions: In the quest to find a suitable therapeutic marker, this study incorporates quantitative labeling and detection followed by flow cytometry, immunocytochemistry, and western blotting for early diagnosis and treatment of meningioma. The article further explores the efficacy of some proteins namely AK2, COL1A1, and PLG to be the targeted molecules.
- 17 September 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (12) , 7434-7446
Open AccessQuantitative tissue analysis reveals AK2, COL1A1, and PLG protein signatures: targeted therapeutics for meningioma
Background: Meningioma is the most prevalent primary intracranial brain tumor and accounts for one-third of all CNS tumors. Meningioma is known to be the most common yet life-threatening brain tumor with a higher recurrence rate. Globally, there is an increase in the healthcare burden due to meningioma and hence in its research. The present clinical approach includes surgical resection, chemotherapy, and radiation therapies to which the malignancy does not seem to respond efficiently. Targeted therapies and molecular markers provide elite patient treatment and care for individuals suffering from meningiomas as compared to conventional measures. Although there is proteomic data on meningioma the knowledge of potential biomarkers differentiating the grades is scarce. To identify the best set of biomarkers, validation of reported markers in large and independent sample cohorts in the future is necessary. Methods: A total of 12 samples, 3 each of control (which made pool 1) meningioma grade I (which made 2 sets: pool 2 and pool 3), and meningioma grade II (which made pool 4) were taken for LC-MS/MS. After this, the expression of three proteins was checked by immunocytochemistry, flow cytometry, and western blotting. Results: Protein expression was analyzed using various techniques like mass spectrometry, immunocytochemistry, flow cytometry, and western blotting. Mass spectrometry is the most commonly used standard and reliable technique for identifying and quantifying protein expression. We got three highly upregulated proteins namely AK2, COL1A1, and PLG using this technique. The biomarker potential of these proteins was further checked by ICC, western blotting, and flow cytometry. Three important proteins were found to be upregulated namely, AK2 (Adenylate kinase 2), COL1A1 (collagen 1A1), and PLG (plasminogen). The order of increased protein expression was control < MG grade I < MG grade II according to mass spectrometry and western blotting. In immunocytochemistry, we found that COL1A1 expression increases significantly with grades in comparison to control. Similarly, AK2 and PLG also showed little increase but not as much as COL1A1. In flow cytometry, PLG showed higher upregulation in grades than control. While AK2 and COL1A1 showed little increase in expression in grades than control. All techniques, especially mass spectrometry and western blotting, presented higher expression of these proteins in grades as compared to control. Conclusions: In the quest to find a suitable therapeutic marker, this study incorporates quantitative labeling and detection followed by flow cytometry, immunocytochemistry, and western blotting for early diagnosis and treatment of meningioma. The article further explores the efficacy of some proteins namely AK2, COL1A1, and PLG to be the targeted molecules.
- Open Access
- 12 October 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (1) , 507-519
Impact of antibiotic-coated sutures on surgical site infections: a second-order meta-analysis
Background: Surgical site infections (SSIs) pose a global challenge, impacting patients and healthcare expenditures. This second-order meta-analysis endeavors to assess the efficacy of antibiotic sutures in averting SSIs by amalgamating data from various meta-studies. Materials and methods: This research adhered to the PRISMA 2020 guidelines. The quality and comprehensiveness of the encompassed meta-analyses were assessed through the QUOROM checklist and AMSTAR techniques. The primary study overlap was evaluated via measures such as pairwise intersection heat maps, corrected covered area, and the citation matrix of evidence. The statistical power at the study-level was determined utilizing the meta-meta package. Data synthesis employed random and fixed effects models at a 95% CI. A meta-regression analysis was conducted to explore potential correlations between the CDC classification of SSIs, trial types, and the observed effect sizes in the studies. Results: This investigation revealed a significant reduction in SSI rates due to antimicrobial-coated sutures, evidenced by a relative risk (RR) of 0.68 (95% CI: 0.59–0.76), with a prediction interval of 0.38–1.19. The analysis encompassed 18 studies with 22 meta-analyses, demonstrating a median QUOROM score of 13.6 out of 18 and an AMSTAR score of 9.1 out of 11. The presence of moderate heterogeneity was noted (Q=106.611, I 2=54.038%), with nonrandomized controlled trials exhibiting an RR of 0.56 (95% CI: 0.39–0.80), and RCTs displaying an RR of 0.71 (95% CI: 0.63–0.81). Subgroup analysis unveiled variable RR reductions for specific surgical procedures. Conclusion: Antimicrobial-coated sutures offer a promising approach to mitigating SSIs risk. However, their efficacy is optimally realized when employed in conjunction with other robust practices.
- 12 October 2023
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (1) , 507-519
Open AccessImpact of antibiotic-coated sutures on surgical site infections: a second-order meta-analysis
Background: Surgical site infections (SSIs) pose a global challenge, impacting patients and healthcare expenditures. This second-order meta-analysis endeavors to assess the efficacy of antibiotic sutures in averting SSIs by amalgamating data from various meta-studies. Materials and methods: This research adhered to the PRISMA 2020 guidelines. The quality and comprehensiveness of the encompassed meta-analyses were assessed through the QUOROM checklist and AMSTAR techniques. The primary study overlap was evaluated via measures such as pairwise intersection heat maps, corrected covered area, and the citation matrix of evidence. The statistical power at the study-level was determined utilizing the meta-meta package. Data synthesis employed random and fixed effects models at a 95% CI. A meta-regression analysis was conducted to explore potential correlations between the CDC classification of SSIs, trial types, and the observed effect sizes in the studies. Results: This investigation revealed a significant reduction in SSI rates due to antimicrobial-coated sutures, evidenced by a relative risk (RR) of 0.68 (95% CI: 0.59–0.76), with a prediction interval of 0.38–1.19. The analysis encompassed 18 studies with 22 meta-analyses, demonstrating a median QUOROM score of 13.6 out of 18 and an AMSTAR score of 9.1 out of 11. The presence of moderate heterogeneity was noted (Q=106.611, I 2=54.038%), with nonrandomized controlled trials exhibiting an RR of 0.56 (95% CI: 0.39–0.80), and RCTs displaying an RR of 0.71 (95% CI: 0.63–0.81). Subgroup analysis unveiled variable RR reductions for specific surgical procedures. Conclusion: Antimicrobial-coated sutures offer a promising approach to mitigating SSIs risk. However, their efficacy is optimally realized when employed in conjunction with other robust practices.